Aterian (ATER) Cash & Equivalents (2018 - 2026)

Aterian has reported Cash & Equivalents for 9 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 83.79% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 83.79% YoY), and the FY2025 full-year result was $4.9 million, down 73.01% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.3 million, down from $4.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $44.3 million in Q1 2022, with the low at $2.3 million in Q1 2026.
• Average Cash & Equivalents over 5 years is $22.0 million, with a median of $20.0 million recorded in 2023.
• Year-over-year, Cash & Equivalents surged 43.73% in 2022 and slumped 83.79% in 2026.
• Tracing ATER's Cash & Equivalents over 5 years: stood at $43.6 million in 2022, then plunged by 54.05% to $20.0 million in 2023, then slipped by 10.11% to $18.0 million in 2024, then plunged by 73.01% to $4.9 million in 2025, then slumped by 52.15% to $2.3 million in 2026.
• The last three Cash & Equivalents figures came in at $2.3 million (Q1 2026), $4.9 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison